Price Alert

Amphastar Pharmaceuticals... (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

29.87

-0.34 (-1.13%)

At close: Aug 15, 2025, 3:59 PM

29.83

-0.13%

After-hours: Aug 15, 2025, 07:19 PM EDT

Amphastar Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	174.41M	170.53M	186.52M	188.82M	182.39M	171.84M	178.1M	180.56M	145.71M	140.02M	135.02M	120.13M	123.47M	120.37M	120.89M	112.2M	101.66M	103.02M
Cost of Revenue	87.92M	85.28M	99.88M	86.88M	90.35M	84.55M	84.54M	72.15M	72.97M	66.18M	63.85M	61.62M	60.11M	64.54M	64.65M	61.02M	54.29M	58.07M
Gross Profit	86.49M	85.25M	86.65M	101.94M	92.05M	87.29M	93.57M	108.4M	72.74M	73.84M	71.17M	58.51M	63.36M	55.83M	56.23M	51.18M	47.38M	44.95M
Operating Income	42.18M	37.29M	45.14M	57.05M	55.22M	48.01M	53.98M	72.68M	36.9M	26.04M	37.83M	15.74M	24.82M	29.39M	24.25M	24.77M	10.56M	10.31M
Interest Income	1.92M	2.09M	2.29M	2.43M	3.34M	2.56M	2.3M	1.2M	1.03M	924K	580K	331K	229K	181K	157K	141K	142K	161K
Pretax Income	39.34M	30.86M	43.96M	47.68M	50.24M	47.3M	40.84M	63.25M	32.81M	33.57M	41.26M	22.6M	23.15M	29.03M	27.16M	37.65M	14.22M	5.11M
Net Income	31.03M	25.29M	37.96M	40.43M	37.95M	43.18M	36.17M	49.22M	26.12M	26.03M	33.91M	15.87M	17.35M	24.25M	19.76M	29.55M	7.77M	5.04M
Selling & General & Admin	24.23M	27.86M	23.36M	23.82M	22.3M	25.05M	21.74M	19.06M	19M	20.59M	16.1M	16.77M	15.73M	17.99M	14.7M	15.65M	18.69M	19.88M
Research & Development	20.08M	20.1M	18.14M	21.08M	17.65M	14.23M	17.85M	16.66M	16.84M	19.82M	17.24M	18.51M	22.8M	16.22M	17.29M	10.76M	18.12M	14.77M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	136K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	44.31M	47.96M	41.5M	44.89M	39.95M	39.28M	39.59M	35.73M	35.84M	40.41M	33.34M	35.28M	38.53M	34.21M	31.98M	26.41M	36.82M	34.64M
Interest Expense	6.28M	6.29M	6.42M	6.7M	8.61M	8.61M	9.46M	13.7M	3.6M	398K	528K	566K	397K	355K	168K	527K	86K	104K
Selling & Marketing Expenses	10.23M	11.87M	10.42M	8.99M	9.01M	9.37M	8.62M	6.41M	6.72M	7.11M	5.47M	4.78M	5.76M	5.52M	4.08M	4.75M	4.13M	4.54M
Cost & Expenses	132.23M	133.24M	141.38M	131.77M	127.18M	123.83M	124.13M	107.88M	108.82M	106.59M	97.19M	96.9M	98.64M	98.75M	96.64M	87.43M	91.1M	92.71M
Income Tax Expense	8.3M	5.58M	6M	7.25M	12.29M	4.13M	4.67M	14.03M	6.38M	6.75M	7.29M	6.56M	5.55M	4.08M	7.19M	6.69M	5.59M	1.16M
Shares Outstanding (Basic)	46.95M	47.64M	48.43M	48.62M	48.91M	48.21M	47.96M	48.7M	48.4M	48M	48.3M	52.79M	48.86M	51.6M	47.84M	48.02M	47.73M	47.52M
Shares Outstanding (Diluted)	48.13M	49.89M	52.06M	51.86M	52.05M	53.01M	53.01M	53.92M	53.1M	51.97M	51.72M	52.79M	53.23M	51.98M	50.06M	50.01M	49.55M	49.52M
EPS (Basic)	0.66	0.53	0.78	0.83	0.78	0.90	0.75	1.01	0.54	0.54	0.70	0.30	0.35	0.47	0.41	0.62	0.16	0.11
EPS (Diluted)	0.64	0.51	0.74	0.78	0.73	0.81	0.68	0.91	0.49	0.50	0.66	0.30	0.33	0.47	0.39	0.59	0.16	0.10
EBITDA	61.85M	52.35M	65.05M	68.81M	69.36M	61.97M	67.77M	90.91M	43.43M	41.36M	49.22M	23.23M	24.82M	36.18M	33.88M	44.68M	21.17M	12.04M
EBIT	45.62M	37.15M	50.39M	54.38M	55.22M	48.01M	53.98M	77.34M	36.9M	33.97M	37.83M	23.23M	24.82M	21.61M	27.33M	24.77M	10.56M	10.31M
Depreciation & Amortization	16.24M	15.21M	14.66M	14.43M	14.14M	13.96M	13.79M	13.57M	7.02M	7.4M	7.43M	7.49M	7.02M	6.79M	6.55M	6.51M	6.87M	6.83M